NPPES file of Aug 9, 2026

Gennady G. Miroshnichenko, MD

Gynecologic Oncology Physician · Fort Worth, TX

Gennady G. Miroshnichenko, MD is a gynecologic oncology physician with a practice address in Fort Worth, Texas, and NPI 1164784450, issued on Jun 12, 2012. Check the license (Texas P4595, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1164784450
Name
Gennady G. Miroshnichenko
Credential
MD
Primary taxonomy
Gynecologic Oncology Physician 207VX0201X
License number
P4595 TX
Self-reported in NPPES; status is on the state search
Practice location
1201 S Main St, Fort Worth, TX 76104
Phone
(817) 702-6500
Enumerated
Jun 12, 2012
Record last updated
Feb 1, 2021 (not updated in 5 years: call before relying on the address or phone)
Fax
(817) 702-6561
Medicaid ID
307460101 TX
Medicare enrollment
Enrolled (PECOS I20121012000700); accepts Medicare assignment
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1201 S Main St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Mallory AshmorePharmacist Clinician (PhC)/ Clinical Pharmacy Specialist1184398208
  2. Tania Ayala, APRN-CNPWomen's Health Nurse Practitioner1891579355
  3. Aurora Bustillos, RNC-MNN, IBCLCLactation Consultant (Registered Nurse)1891080404
  4. Stephanie Carson Henderson, MDObstetrics & Gynecology Physician1952386104
  5. Emily Hadley, MDMaternal & Fetal Medicine Physician1184917841
  6. Norvelyn Tusil ImbongDiabetes Educator Registered Nurse1225915267

Verify Gennady G. Miroshnichenko in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license P4595
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

25% more Medicare Part D claims than the average gynecologic oncology physician in 2024

244 Medicare Part D claims for 44 beneficiaries, against an average of 195 among the 1,475 providers of this specialty who prescribed in Part D. Brand-name drugs were 12% of claims.

  1. Gennady Miroshnichenko244
  2. Specialty average195

Most prescribed

  1. Ondansetron Hcl33 claims
  2. Dexamethasone29 claims
  3. Prochlorperazine Maleate27 claims
  4. Olanzapine13 claims
  5. Rubraca13 claims
  6. Estradiol11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 92 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score89.8
  2. Costout of 100 · 30%56.8
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $1,472.41

8 payments; by number, the most common kind was food and beverage; the largest payer was Intuitive Surgical, Inc. The 1,199 providers of this specialty with any payment received $6,387.20 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Gennady Miroshnichenko$1,472.41
  2. Specialty average$6,387.20

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Acclaim Physician Group IncFort Worth, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Gennady G. Miroshnichenko among 149 gynecologic oncology physician records in Texas

Gennady G. Miroshnichenko, MD is one of 149 gynecologic oncology physician records with a practice address in Texas. 89% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2012, is newer than 72% of them.

  • NPI issued2012 · 72% of these records are older, 25% newer
  • In a Medicare fileYes · 89% of these records are
  • In the CMS Doctors and Clinicians fileYes · 80% of these records are
  • Graduated1994 · median 2006 among the 119 with a school on file
  • Record last updated2021 · 48% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207VX0201X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Gynecologic Oncology Physician providers in Texas

There are 149 gynecologic oncology physician records in Texas.

The 8 gynecologic oncology physician records with the nearest ZIP codes

  1. Martins Ayoola, MDFt Worth, TX 761041881191732
  2. Graham Brown, DOFort Worth, TX 761041912385071
  3. Noelle Cloven, M.D.Fort Worth, TX 761041477518686
  4. Kenneth Hancock, M.D.Fort Worth, TX 761041467495325
  5. Christopher Lafargue, M.D.Fort Worth, TX 761041306286166
  6. Tiffany Redfern, M.D.Fort Worth, TX 761041679984363
  7. Reagan Street, MDFort Worth, TX 761041487845673
  8. Deette Vasques, DOFort Worth, TX 761041093743098

Common questions

What is Gennady G. Miroshnichenko, MD's NPI number?

Gennady G. Miroshnichenko, MD's National Provider Identifier (NPI) is 1164784450, issued on Jun 12, 2012. An NPI identifies a provider in billing; it is not a license.

Where is Gennady G. Miroshnichenko, MD located?

The NPPES record lists a practice address at 1201 S Main St, Fort Worth, TX, 76104. Phone: (817) 702-6500. Providers update this record themselves, so call before visiting.

How can I verify Gennady G. Miroshnichenko, MD's license?

NPPES lists Texas license number P4595, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Gennady G. Miroshnichenko, MD prescribe under Medicare Part D?

In 2024, Gennady G. Miroshnichenko, MD had 244 Medicare Part D claims for 44 beneficiaries; the average among gynecologic oncology physician prescribers was 195. Part D covers Medicare prescriptions only.

What is Gennady G. Miroshnichenko, MD's MIPS final score?

The 2023 MIPS final score is 92 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.